These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13888007)

  • 1. Carcinoid syndrome: alleviation of diarrhoea and flushing with "Deseril" and Ro 5-1025.
    DUBACH UC; GSELL OR
    Br Med J; 1962 May; 1(5289):1390-1. PubMed ID: 13888007
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of a serotonin antagonist (UML 491) in carcinoid disease.
    PEART WS; ROBERTSON JI
    Lancet; 1961 Nov; 2(7213):1172-4. PubMed ID: 14484792
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the treatment of headache with Deseril].
    BRZECKI A
    Pol Tyg Lek; 1962 Mar; 17():440-2. PubMed ID: 13874157
    [No Abstract]   [Full Text] [Related]  

  • 4. COMPARATIVE STUDY OF ANTISEROTONIN EFFECTS OF LYSENYL AND DESERIL.
    RYSANEK K; VITEK V
    Gastroenterologia; 1964; 102():1-10. PubMed ID: 14187206
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observations on a case of carcinoid syndrome. Anti-serotonin treatment after resection of the small intestine].
    LANZ R
    Schweiz Med Wochenschr; 1960 Sep; 90():1046-8. PubMed ID: 15445408
    [No Abstract]   [Full Text] [Related]  

  • 6. [EFFECT OF THE SEROTONIN ANTAGONIST DESERIL (1-METHYL-LYSERGIC ACID BUTANOLAMIDE) ON THE TOTAL CATECHOLAMINE LEVEL IN WHOLE BLOOD AND ITS ROLE IN THE CARCINOID SYNDROME (CASSIDY-SCHOLTE)].
    UNGHVARY L; HOVANYI M; GOERGENYI F; FARKAS F
    Z Kreislaufforsch; 1963 Nov; 52():1125-8. PubMed ID: 14097993
    [No Abstract]   [Full Text] [Related]  

  • 7. Facial flushes and diarrhoea.
    Crasset V; Delcourt E
    Postgrad Med J; 1997 Jun; 73(860):337-8. PubMed ID: 9246332
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.
    Ruszniewski P; Valle JW; Lombard-Bohas C; Cuthbertson DJ; Perros P; Holubec L; Delle Fave G; Smith D; Niccoli P; Maisonobe P; Atlan P; Caplin ME;
    Dig Liver Dis; 2016 May; 48(5):552-558. PubMed ID: 26917486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The control of flushing and diarrhoea in carcinoid syndrome by an antiserotonin agent, BC105.
    Loong SC; Lance JW; Rawle KC
    Med J Aust; 1968 Nov; 2(19):845-8. PubMed ID: 5728213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary determination of serotonin in allergic patients. Clinical and biological effects of an antagonist, UML 491 (Deseril Sandoz)].
    GIRARD JP
    Helv Med Acta; 1961 Sep; 28():476-81. PubMed ID: 13898854
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoid syndrome. Medical management.
    Clarke B; Hodgson HJ
    Br J Hosp Med; 1986 Mar; 35(3):146-8, 150, 152. PubMed ID: 3742126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREATMENT OF MALABSORPTION AND DIARRHEA OF THE CARCINOID SYNDROME WITH METHYSERGIDE.
    MELMON KL; SJOERDSMA A; OATES JA; LASTER L
    Gastroenterology; 1965 Jan; 48():18-24. PubMed ID: 14252749
    [No Abstract]   [Full Text] [Related]  

  • 13. Complications of midgut carcinoid tumors and carcinoid syndrome.
    van der Horst-Schrivers AN; Wymenga AN; Links TP; Willemse PH; Kema IP; de Vries EG
    Neuroendocrinology; 2004; 80 Suppl 1():28-32. PubMed ID: 15477713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.
    Ruszniewski P; Ducreux M; Chayvialle JA; Blumberg J; Cloarec D; Michel H; Raymond JM; Dupas JL; Gouerou H; Jian R; Genestin E; Bernades P; Rougier P
    Gut; 1996 Aug; 39(2):279-83. PubMed ID: 8977344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of chronic diarrhea after resection of a localized pulmonary carcinoid tumor.
    Schieman C; Pasieka JL; McFadden SD; Cole M; Graham AJ
    Ann Thorac Surg; 2010 Apr; 89(4):1275-6. PubMed ID: 20338354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical observations on LSD-25 and Deseril.
    DOEPFNER W
    Experientia; 1962 Jun; 18():256-7. PubMed ID: 13886913
    [No Abstract]   [Full Text] [Related]  

  • 18. CLINICAL FEATURES IN PATIENTS WITH THE CARCINOID SYNDROME.
    SMITH AN; PRESHAW RM; SIRCUS W
    Gastroenterology; 1965 Jun; 48():738-44. PubMed ID: 14300170
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.